Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 5, 2012, Pages 612-614

  Li, X ^a   Wang, Haiying ^a   Jing, H ^a   Wang, Y ^a   Yu, C ^a   Wang, J ^a   Liu, Z ^a   Graviss, E A ^b   Ma, Xin ^a,b  

^a SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Extensively drug resistant tuberculosis; Multidrug resistant tuberculosis; Mycobacterium tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; LEVOFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; CHINA; CHINESE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHINA; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84859699470     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0507     Document Type: Article

References (11)

1. Stop TB Department, World Health Organization. Countries that had reported at least one XDR-TB case by end 2010. Geneva, Switzerland: WHO, 2011. http://www.who.int/tb/challenges/mdr/drs-maps-feb2011.pdf Accessed January 2012.
2. Wright A, Zignol M, Van Deun A, et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 2009; 373: 1861-1873.
3. Jackson S, Sleigh A C, Wang G-J, Liu X-L. Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis 2006; 10: 1104-1110. (Pubitemid 44519347)
4. Chinese Medical Association. Clinical techniques standard operating procedures: tuberculosis section. Beijing, China: People's Military Medical Press, 2004.
5. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva, Switzerland: WHO, 2006.
6. World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. WHO/HTM/TB/2010.3. Geneva, Switzerland: WHO, 2010.
7. Sun Z, Chao Y, Zhang X, et al. Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J Clin Microbiol 2008; 46: 4075-4077.
8. Zhao M, Li X, Xu P, et al. Transmission of MDR and XDR tuberculosis in Shanghai, China. PloS ONE 2009; 4: e4370.
9. Deng Y, Wang Y, Wang J, et al. Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis 2011; 17: 495-497.
10. Tang S, Zhang Q, Yu J, et al. Extensively drug-resistant tuberculosis, China. Emerg Infect Dis 2011; 17: 558-560.
11. He G X, van den Hof S, Borgdorff M W, et al. Availability of second-line drugs and anti-tuberculosis drug susceptibility testing in China: a situational analysis. Int J Tuberc Lung Dis 2010; 14: 884-889.